Invatin Technologies Ltd

Invatin Technologies Ltd is a pioneering force in medical equipment manufacturing, dedicated to advancing patient care through innovative solutions. Invatin Technologies Ltd specializes in developing cutting-edge medical devices, including the SYNAXIS, a first-in-class permanent aortic implantable apparatus designed for the diversion of thromboembolic materials away from the brain. This groundbreaking technology addresses the critical needs of patients with atrial fibrillation (AF), high stroke risk, and high bleeding risk, offering a novel approach to stroke prevention. Located at Barnea St, Industry Park, Katzerin, 1290000, IL, Invatin Technologies Ltd is committed to improving patient outcomes worldwide.

The SYNAXIS device developed by Invatin Technologies Ltd represents a significant advancement in stroke prevention. Its unique design, featuring a one-piece cylindrical endovascular graft, ensures sustainability and high performance. Rigorous animal studies have demonstrated both the safety and preclinical efficacy of the SYNAXIS in acute and chronic swine models of cerebral embolism. Invatin Technologies Ltd is actively exploring collaborations with manufacturers, distributors, and traditional medical device companies to expand the reach of this life-changing technology. Invatin Technologies Ltd received investments from Clalit, the largest Israeli HMO, which may facilitate local and international implementation.

Invatin Technologies Ltd continues to push the boundaries of medical innovation, striving to provide superior alternatives for patients who cannot be treated with conventional measures. With a focus on patient safety and clinical efficacy, Invatin Technologies Ltd is poised to make a lasting impact on the field of stroke prevention and beyond. We invite the manager of Invatin Technologies Ltd to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.